Eagle Pharmaceuticals Inc.

NAS: EGRX

GO
/marketstate/country/us

Market open

/zigman2/quotes/200611523/composite

$

46.34

Change

-0.06 -0.13%

Volume

Volume 5,270

Jan 20, 2022, 9:37 a.m.

Real time quotes

/zigman2/quotes/200611523/composite

Previous close

$ 46.40

$ 46.34

Change

-0.06 -0.13%

Day low

Day high

$46.34

$46.52

Open
Open: 46.52

52 week low

52 week high

$36.48

$58.25

Open

Market cap

$595.46M

Average volume

111,316

P/E ratio

112.20

Rev. per Employee

$1.69M

EPS

0.41

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/egrx

MarketWatch News on EGRX

  1. Companies Are Starting to Buy Back Stock Again

    10:30 a.m. Sept. 24, 2020

    - Barron's Online

  2. Tyme stock rises on Eage collaboration for cancer drug

    9:25 a.m. Jan. 7, 2020

    - Jaimy Lee

  3. Blackstone’s Interest in Oil

    5:01 a.m. May 18, 2019

    - Barron's Online

  4. Eagle Pharma says FDA has requested another clinical trial for heat stroke drug

    11:36 a.m. July 26, 2017

    - Emma Court

  5. Eagle Pharma stock halted on news that heat stroke drug failed to get FDA approval

    11:36 a.m. July 26, 2017

    - Emma Court

  6. Starboard Value Sees Possible Sale of Parexel

    12:23 a.m. May 20, 2017

    - Barron's Online

  7. 15 companies with outsized sales growth and widening profit margins

    7:33 a.m. April 7, 2017

    - Philip van Doorn

  8. Activist JCP Sees Opportunities for Fiesta Restaurant Group

    12:50 a.m. Oct. 1, 2016

    - Barron's Online

  9. Nasdaq tags uncharted territory, S&P 500 presses the range top

    11:02 a.m. Sept. 7, 2016

    - Michael Ashbaugh

  10. Viex Likes Immersion

    11:44 p.m. Aug. 26, 2016

    - Barron's Online

  11. Elliott Associates Wants to Unlock Value in Imperva

    11:08 p.m. July 8, 2016

    - Barron's Online

  12. Hudson Executive Capital Eyes Eagle Pharmaceuticals

    11:29 p.m. July 1, 2016

    - Barron's Online

  13. S&P, Dow challenge the 200-day average from underneath

    10:43 a.m. Nov. 18, 2015

    - Michael Ashbaugh

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/egrx

Other News on EGRX

  1. 4 High Earnings Yield Stocks Likely to Pay Off Big Time

    9:24 a.m. Dec. 23, 2021

    - Zacks.com

  2. Eagle Pharma wins FDA approval for generic vasopressin

    2:06 p.m. Dec. 15, 2021

    - Seeking Alpha

  3. Eagle Pharmaceuticals EPS misses by $0.27, misses on revenue

    6:54 a.m. Nov. 9, 2021

    - Seeking Alpha

  4. Eagle Pharmaceuticals Q3 2021 Earnings Preview

    11:52 a.m. Nov. 8, 2021

    - Seeking Alpha

  5. Notable earnings before Tuesday's open

    10:52 a.m. Nov. 8, 2021

    - Seeking Alpha

  6. Endo: A Win In California But Equity Value Still A Question

    6:44 p.m. Nov. 2, 2021

    - Seeking Alpha

  7. Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down

    12:39 p.m. Oct. 28, 2021

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/egrx

Press Releases on EGRX

  1. Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin

    11:08 a.m. Jan. 18, 2022

    - BusinessWire - BZX

  2. Eagle Pharmaceuticals Receives FDA Approval for Vasopressin

    1:54 p.m. Dec. 15, 2021

    - BusinessWire - BZX

  3. Eagle Pharmaceuticals Reports Third Quarter 2021 Results

    6:50 a.m. Nov. 9, 2021

    - BusinessWire - BZX

  4. Eagle Pharmaceuticals to Present at September Healthcare Conferences

    4:00 p.m. Sept. 1, 2021

    - BusinessWire - BZX

  5. Eagle Pharmaceuticals Wins Vasopressin Patent Trial

    10:45 a.m. Aug. 31, 2021

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.